Candriam S.C.A. Pfizer Inc Transaction History
Candriam S.C.A.
- $16.8 Billion
- Q2 2025
A detailed history of Candriam S.C.A. transactions in Pfizer Inc stock. As of the latest transaction made, Candriam S.C.A. holds 2,240,955 shares of PFE stock, worth $55.1 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
2,240,955
Previous 1,659,600
35.03%
Holding current value
$55.1 Million
Previous $42.1 Million
29.17%
% of portfolio
0.32%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding PFE
# of Institutions
3,330Shares Held
3.61BCall Options Held
104MPut Options Held
129M-
Vanguard Group Inc Valley Forge, PA523MShares$12.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.4 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.3 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA127MShares$3.13 Billion0.22% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.54 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $138B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...